Magnetic Resonance Spectroscopy Detectable Metabolomic Fingerprint of Response to Antineoplastic Treatment

Nuclear Magnetic Resonance Detects Phosphoinositide 3-Kinase/Akt-Independent Traits Common to Pluripotent Murine Embryonic Stem Cells and Their Malignant Counterparts

(2015) Hanna M. Romanska et al.   NEOPLASIA

Early Stage Diagnosis of Oral Cancer Using 1H NMR–Based Metabolomics

(2015) Stefano Tiziani et al.   NEOPLASIA

On-target Inhibition of Tumor Fermentative Glycolysis as Visualized by Hyperpolarized Pyruvate

(2015) Pankaj Seth et al.   NEOPLASIA

Hypoxia Triggers Major Metabolic Changes in AML Cells without Altering Indomethacin-Induced TCA Cycle Deregulation

(2010) Alessia Lodi et al.   ACS Chemical Biology

The INTERPRET Decision-Support System version 3.0 for evaluation of Magnetic Resonance Spectroscopy data from human brain tumours and other abnormal brain masses

(2010) Alexander Pérez-Ruiz et al.   BMC BIOINFORMATICS

Magnetic Resonance Metabolomics of Intact Tissue: A Biotechnological Tool in Cancer Diagnostics and Treatment Evaluation

(2010) T. F. Bathen et al.   CANCER RESEARCH

The Phosphoinositide 3-Kinase Inhibitor PI-103 Downregulates Choline Kinase   Leading to Phosphocholine and Total Choline Decrease Detected by Magnetic Resonance Spectroscopy

(2010) N. M. S. Al-Saffar et al.   CANCER RESEARCH

Noninvasive Detection of Target Modulation following Phosphatidylinositol 3-Kinase Inhibition Using Hyperpolarized 13C Magnetic Resonance Spectroscopy

(2010) C. S. Ward et al.   CANCER RESEARCH

Hyperpolarized 13C Spectroscopic Imaging Informs on Hypoxia-Inducible Factor-1 and Myc Activity Downstream of Platelet-Derived Growth Factor Receptor

(2010) H. Dafni et al.   CANCER RESEARCH

The PI3K Pathway As Drug Target in Human Cancer

(2010) Kevin D. Courtney et al.   JOURNAL OF CLINICAL ONCOLOGY

Clues from cell metabolism

(2010) William G. Kaelin et al.   NATURE

Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma

(2010) D. Koul et al.   NEURO-ONCOLOGY

Tumor suppressors and cell metabolism: a recipe for cancer growth

(2009) R. G. Jones et al.   GENES & DEVELOPMENT

Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r

(2009) H. Carl Le et al.   MAGNETIC RESONANCE IN MEDICINE

Changes in choline metabolism as potential biomarkers of phospholipase C 1 inhibition in human prostate cancer cells

(2009) M. Beloueche-Babari et al.   MOLECULAR CANCER THERAPEUTICS

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

(2009) Ping Gao et al.   NATURE

Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines

(2009) Stefano Tiziani et al.   PLoS One

Hyperpolarized 13C Lactate, Pyruvate, and Alanine: Noninvasive Biomarkers for Prostate Cancer Detection and Grading

(2008) M. J. Albers et al.   CANCER RESEARCH

Cancer Cell Metabolism: Warburg and Beyond

(2008) Peggy P. Hsu et al.   CELL

Metabolic Profiling of Human Colorectal Cancer Using High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) Spectroscopy and Gas Chromatography Mass Spectrometry (GC/MS)

(2008) Eric Chun Yong Chan et al.   JOURNAL OF PROTEOME RESEARCH

Human metabolic phenotype diversity and its association with diet and blood pressure

(2008) Elaine Holmes et al.   NATURE

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

(2008) D. R. Wise et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA